B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

THPO

MOLECULAR TARGET

thrombopoietin

UniProt: AAI30323NCBI Gene: 706624 compounds

THPO (thrombopoietin) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting THPO

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Genistein0.691
2myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
3Spermidine0.691
4Amoxapine0.691
5Azacitidine0.691
6Azacitidine0.691
7Camptothecin0.691
8Clotrimazole0.691
9Disulfiram0.691
10Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
11Ethylmaleimide0.691
12Fluspirilene0.691
13Iodoacetamide0.691
14kenpaullone0.691
15Metergoline0.691
16Niclosamide0.691
17Papaverine0.691
18pd980590.691
19Perphenazine0.691
20protriptyline0.691
21Pseudoephedrine0.691
22Reserpine0.691
23Salmeterol Xinafoate0.691
24tyrphostin 90.691

About THPO as a Drug Target

THPO (thrombopoietin) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented THPO interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

THPO inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.